Lachlan Hanbury Brown
Stock Analyst at William Blair
(0.20)
# 4,452
Out of 5,028 analysts
146
Total ratings
36.3%
Success rate
-9.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Hanbury Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Reiterated: Buy | n/a | $30.58 | - | 22 | Oct 5, 2026 | |
| SRZN Surrozen | Reiterated: Buy | n/a | $29.13 | - | 4 | Oct 2, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | n/a | $10.99 | - | 8 | Sep 30, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | n/a | $10.70 | - | 3 | Sep 30, 2026 | |
| QURE uniQure | Reiterated: Buy | n/a | $22.80 | - | 1 | Sep 29, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | n/a | $17.49 | - | 1 | Sep 28, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | n/a | $7.25 | - | 20 | Sep 25, 2026 | |
| SPRY ARS Pharmaceuticals | Reiterated: Buy | n/a | $4.29 | - | 28 | Aug 14, 2026 | |
| LENZ LENZ Therapeutics | Reiterated: Buy | n/a | $3.59 | - | 20 | Aug 12, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | n/a | $74.46 | - | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.83 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.00 | - | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.06 | - | 2 | Mar 20, 2026 |
Harrow
Oct 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.58
Upside: -
Surrozen
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.13
Upside: -
Eupraxia Pharmaceuticals Inc.
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.99
Upside: -
Zevra Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.70
Upside: -
uniQure
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.80
Upside: -
Sarepta Therapeutics
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.49
Upside: -
Ocular Therapeutix
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.25
Upside: -
ARS Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.29
Upside: -
LENZ Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.59
Upside: -
Tarsus Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $74.46
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.83
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.00
Upside: -
Mar 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.06
Upside: -